Barclays’s Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 PNTM.WS Stock Holding History

Barclays’s Portfolio PNTM.WS Stock Details PNTM.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-333	Closed	-$57	–	5300
2023 Q1	$57	Hold	333	–	–	﹤0.01%	5009
2022 Q4	$27	Hold	333	–	–	﹤0.01%	5225
2022 Q3	$0	Hold	333	–	–	﹤0.01%	5261
2022 Q2	$0	Hold	333	–	–	﹤0.01%	5398
2022 Q1	$0	Buy	+333	New	+$158	﹤0.01%	5779

Barclays's PNTM.WS Position: Q2 2023 in Review

Barclays sold out of Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (PNTM.WS) in Q2 2023, closing a stake of 333 shares — an estimated $57 sold.

Barclays first reported a position in PNTM.WS in Q1 2022 and held it in 5 quarters. The position peaked at $57 in Q1 2023. 0 funds tracked by Wall St. Rank hold PNTM.WS as of Q2 2023.

Barclays reported no remaining Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q2 2023 after selling out during the quarter.
Barclays sold 333 Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q2 2023, an estimated $57.
Barclays first reported a position in Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2022 and held it in 5 quarters.
Barclays's Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $57 in Q1 2023.
0 funds tracked by Wall St. Rank held Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q2 2023.

Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.